Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 59 publications
Synergistic effects through targeting the PI3K and IGFR pathways in treating lung cancer carrying activation alterations along the PI3K pathway.
Journal: Translational oncology
Published: February 17, 2026
A Mitochondrial Plasma Proteomic Signature Identifies Metastatic Chromophobe Renal Cell Carcinoma.
Journal: Cancers
Published: February 08, 2026
Epigenetic Atlas of Bladder Cancer Reveals Master Transcription Factors and Risk-Associated Regulatory Elements in Luminal and Basal-Squamous Molecular Subtypes.
Journal: Molecular cancer research : MCR
Published: December 19, 2025
Epigenetic Atlas of Bladder Cancer Reveals Master Transcription Factors and Risk-Associated Regulatory Elements in Luminal and Basal-Squamous Molecular Subtypes.
Journal: Molecular cancer research : MCR
Published: December 19, 2025
Exploring glucocorticoid receptor signalling in lymphangioleiomyomatosis.
Journal: ERJ open research
Published: September 22, 2025
TIGAR deficiency enhances cardiac resilience through epigenetic programming of Parkin expression.
Journal: JCI insight
Published: September 11, 2025
Extracellular Matrix and Fibroblast Activation in Lymphangioleiomyomatosis.
Journal: American journal of respiratory cell and molecular biology
Published: April 08, 2025
Targeting KIT With Antibody-Drug Conjugates in Chromophobe Renal Cell Carcinoma.
Journal: Clinical genitourinary cancer
Published: April 01, 2025
Targeting FSP1 to induce ferroptosis in chromophobe renal cell carcinoma.
Journal: Oncogene
Published: March 20, 2025
The Bi-steric Inhibitor RMC-5552 Reduces mTORC1 Signaling and Growth in Lymphangioleiomyomatosis.
Journal: American journal of respiratory cell and molecular biology
Published: November 12, 2024
Clinical advances of mRNA vaccines for cancer immunotherapy.
Journal: Med (New York, N.Y.)
Published: September 13, 2024
Last Updated: 09/26/2026